“We appreciate the continued support of the University of Virginia Licensing & Ventures Group, which is part of a premier university and technology innovation center,” commented William Stilley, CEO of Adial Pharmaceuticals. “This latest amendmen...

These insights underlie PureTech’s approach to designing novel categories of therapeutics to address debilitating and devastating CNS disorders, and the related IP has been exclusively licensed to PureTech Health from the University of Virginia Licen...

Dexcom, TypeZero and the University of Virginia have had a longstanding, productive relationship in developing important technologies for diabetes management, including inControl for integration with both automated insulin delivery (“AID”) and smart ...